Bosh sahifaCRL • NYSE
add
Charles River Lbrtrs ntrntl Inc
219,53 $
Seans yopilganidan keyin:(0,00%)0,00
219,53 $
Yopilgan:27-yan, 16:04:58 (GMT-5) · USD · NYSE · Ogohlantirish
Yopilish kursi
222,35 $
Kunlik diapazon
219,46 $ - 224,78 $
Yillik diapazon
91,86 $ - 228,88 $
Bozor kapitalizatsiyasi
10,80 mlrd USD
Oʻrtacha hajm
663,28 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NYSE
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 1,00 mlrd | -0,49% |
Joriy xarajat | 201,05 mln | -8,50% |
Sof foyda | 54,42 mln | -21,87% |
Sof foyda marjasi | 5,42 | -21,45% |
Har bir ulushga tushum | 2,43 | -6,18% |
EBITDA | 165,25 mln | -30,05% |
Amaldagi soliq stavkasi | 36,29% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 207,10 mln | -1,46% |
Jami aktivlari | 7,51 mlrd | -6,12% |
Jami passivlari | 4,06 mlrd | -2,71% |
Umumiy kapital | 3,45 mlrd | — |
Tarqatilgan aksiyalar | 49,22 mln | — |
Narxi/balansdagi bahosi | 3,21 | — |
Aktivlardan daromad | 5,01% | — |
Kapitaldan daromad | 6,16% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 54,42 mln | -21,87% |
Operatsiyalardan naqd pul | 213,83 mln | -15,08% |
Sarmoyadan naqd pul | -33,70 mln | -58,02% |
Moliyadan naqd pul | -152,62 mln | 26,46% |
Naqd pulning sof oʻzgarishi | 24,48 mln | -20,09% |
Boʻsh pul | 60,91 mln | -72,72% |
Haqida
Charles River Laboratories International, Inc. is an American pharmaceutical and biotechnology contract research organisation headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides preclinical and clinical laboratory services for the development of new drugs, vaccines, and medical devices. Its operations span at least 20 countries, offering research models, safety assessment, and manufacturing support services to pharmaceutical, biotechnology, and government clients.
Charles River Laboratories is considered one of the largest CROs globally, known for its role in toxicology studies, animal research models, and microbial testing services used in regulatory submissions to health authorities such as the U.S. Food and Drug Administration. The company has also been the subject of public scrutiny and regulatory attention over its use of laboratory animals, including dogs, primates, and horseshoe crabs.
As of 2024, the company employs over 20,000 people worldwide and is publicly traded on the New York Stock Exchange under the ticker symbol CRL. Wikipedia
Tashkil etilgan
1947
Sayt
Xodimlar soni
19 400